Sabinsa has been granted three new patents as well as an additional Natural Products Number (NPN) issued by Health Canada, bringing Sabinsa’s total number of products with health claims in Canada to 37.
Sabinsa (East Windor, NJ) has been granted three new patents as well as an additional Natural Products Number (NPN) issued by Health Canada, bringing Sabinsa’s total number of products with health claims in Canada to 37. Patent CA2976689 is for a water-soluble form of curcumin sold by Sabinsa under the name uC3 Clear. The patent discloses a method of solubilizing curcuminoids by using polyvinyl pyrrolidone and sodium bis (2-ethylhexyl) sulfosuccinate to create an aqueous solubility that is enhanced to more than 10%-15% w/v in water.
THE NPN was also for uC3 Clear with the claims:
Patent CA2979287 discloses a concentration-dependent in-vitro anti-tumorigenic activity of a compound isolated from Thai ginger (Zingiber cassumunar) on cancer cells (pancreatic, prostate and ovarian carcinoma). The invention has also been granted patents in the USA (US 9,833,422, US 9,913,809), Australia (AU2016385393), Russia (RU2694053), New Zealand (NZ735027) and Japan (JP 6584526).
The third patent CA2975170, is for the use of the branded Olepent cosmetic peptides in maintaining water hydration by increasing the expression of a water channel protein called aquaporin 5 (AQP5). The cosmetic peptides increase the expression of genes and associated proteins for improving skin barrier function in hydration deficient human skin.
“Our commitment to research and development is continuing to bring innovations that consumers can soon enjoy,” said Sabinsa Founder and Chairman Muhammed Majeed, PhD, in a press release. “These patents provide the added assurance that low quality copycats won’t easily disrupt the marketplace, which protects our customers.”